Amprius Technologies (NYSE:AMPX) Trading Up 8.5% Following Analyst Upgrade

Shares of Amprius Technologies, Inc. (NYSE:AMPX) were up 8.5% on Monday after B. Riley Financial raised their price target on the stock from $16.00 to $22.00. B. Riley Financial currently has a buy rating on the stock. Amprius Technologies traded as high as $17.74 and last traded at $17.7150. Approximately 14,945,477 shares traded hands during mid-day trading, an increase of 65% from the average daily volume of 9,045,669 shares. The stock had previously closed at $16.33.

Several other research firms also recently commented on AMPX. Roth Mkm reiterated a “buy” rating and issued a $20.00 price objective (up from $16.00) on shares of Amprius Technologies in a report on Friday. Cantor Fitzgerald raised their price target on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an “overweight” rating in a report on Friday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. William Blair reissued an “outperform” rating on shares of Amprius Technologies in a report on Friday. Finally, Needham & Company LLC started coverage on shares of Amprius Technologies in a research report on Thursday, January 29th. They set a “buy” rating and a $20.00 price objective on the stock. Eight equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $19.75.

Insider Activity at Amprius Technologies

In other news, CTO Constantin Ionel Stefan sold 25,366 shares of Amprius Technologies stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $10.16, for a total transaction of $257,718.56. Following the transaction, the chief technology officer owned 723,330 shares in the company, valued at $7,349,032.80. This trade represents a 3.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Kang Sun sold 61,251 shares of the company’s stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $10.16, for a total value of $622,310.16. Following the completion of the sale, the director owned 1,342,400 shares of the company’s stock, valued at $13,638,784. This trade represents a 4.36% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 2,392,269 shares of company stock valued at $26,384,359 over the last 90 days. 12.80% of the stock is currently owned by company insiders.

Trending Headlines about Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Multiple analysts raised ratings and price targets (buy ratings and targets in the low-$20s), signaling more institutional conviction and a higher consensus valuation. Read More.
• Positive Sentiment: MarketBeat highlights record trading volume tied to the Q4 release — volume-backed breakouts increase the odds the rally continues because they show real market conviction. Read More.
• Positive Sentiment: Q4 results showed record revenue growth and the company reported its first positive adjusted quarterly EBITDA; management cited expanding adoption of its 2nd‑gen silicon‑anode batteries and new commercial/defense wins. Read More.
• Positive Sentiment: IBD upgraded AMPX, adding a reputable media/ratings endorsement that can attract momentum investors and retail flows. Read More.
• Neutral Sentiment: Analyst fair‑value estimates have moved higher (consensus and some firms into the ~$20–22 range), but coverage remains relatively light — helpful for upside if coverage expands, yet still leaves forecasts dispersed. Read More.
• Negative Sentiment: Despite progress, Amprius remains unprofitable on a GAAP basis and guidance/consensus EPS still negative for the year; valuation and momentum make the stock volatile (high beta), so downside risk exists if growth or NDAA/compliance milestones slip. Read More.

Institutional Trading of Amprius Technologies

Several hedge funds have recently bought and sold shares of AMPX. Alberta Investment Management Corp purchased a new stake in Amprius Technologies in the fourth quarter worth about $1,001,000. Vident Advisory LLC purchased a new position in shares of Amprius Technologies during the 4th quarter valued at about $107,000. Summit Securities Group LLC purchased a new position in shares of Amprius Technologies during the 4th quarter valued at about $54,000. Numerai GP LLC lifted its position in shares of Amprius Technologies by 29.1% during the 4th quarter. Numerai GP LLC now owns 96,209 shares of the company’s stock valued at $759,000 after buying an additional 21,698 shares in the last quarter. Finally, Osterweis Capital Management Inc. grew its stake in shares of Amprius Technologies by 142.6% during the 4th quarter. Osterweis Capital Management Inc. now owns 454,830 shares of the company’s stock valued at $3,589,000 after acquiring an additional 267,385 shares during the period. Institutional investors own 5.04% of the company’s stock.

Amprius Technologies Trading Up 8.5%

The stock has a 50 day moving average of $11.07 and a 200-day moving average of $10.82. The company has a market capitalization of $2.31 billion, a P/E ratio of -52.10 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX) last issued its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.03. The business had revenue of $25.23 million for the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 25.77%. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. As a group, sell-side analysts expect that Amprius Technologies, Inc. will post -0.45 EPS for the current fiscal year.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.